Search Results
May 19, 2026, 08:55 ET Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
company, but one that frames the institutional investor appetite for AI medical platforms more generally. RadNet, Inc. (NASDAQ: RDNT) has built one of the larger imaging-services-plus-AI businesses through its DeepHealth subsidiary. RadNet's recent acquisition of Gleamer — whose
More news about: USA News Group
Mar 03, 2026, 12:19 ET Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), Butterfly Network (NYSE: BFLY), Tempus AI (NASDAQ: TEM), RadNet (NASDAQ: RDNT), and GE HealthCare (NASDAQ: GEHC) are converting clinical validation into contracted hospital deployments.
More news about: USA News Group
Jan 27, 2026, 10:14 ET AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
high-stakes convergence positions VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), Butterfly Network (NYSE: BFLY), RadNet (NASDAQ: RDNT), Nanox Imaging (NASDAQ: NNOX), and OneMedNet (NASDAQ: ONMD) as the essential engineering nodes where software-defined 3D modeling finally
More news about: USA News Group
Oct 23, 2025, 08:30 ET Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
Corp. (NASDAQ: NVDA), Butterfly Network Inc. (NYSE: BFLY), Lantheus Holdings Inc. (NASDAQ: LNTH), and RadNet Inc. (NASDAQ: RDNT), all of which are driving the integration of artificial intelligence into the future of medical imaging.
More news about: NetworkNewsWire